![\"\"](\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/logo-bhiva-2019-text-300x240.png\"){kind=logo}
Simon\u00a0Collins,\u00a0HIV\u00a0i-Base<\/b><\/p>\nSimon\u00a0Collins,\u00a0HIV\u00a0i-Base<\/b><\/p>\n
Most of the key presentations from BHIVA 2019, including oral abstracts and invited lectures, are available online.<\/strong><\/p>\n Webcasts are for the whole session (rather than being separate for each talk) but these can be advanced until the right position is found. Please refer to the main programmed to estimate how far to advance these times.<\/p>\n A selection of talks is included below.<\/p>\n New hepatitis data: hepatitis C in people with and without HIV, lessons learned from the hepatitis A outbreak<\/strong> Declining HIV incidence: is it all good news?<\/strong> Smoking: are e-cigarettes the solution? Immune reconstitution inflammatory syndrome (IRIS)<\/strong> Pregnancy and breastfeeding<\/strong>
\nAndrew Ustianowski, North Manchester General Hospital
\n<\/span>https:\/\/www.bhiva.org\/190403-1<\/a> \u00a0 (at 28 mins)<\/p>\n
\nValerie Delpech, Public Health England
\nhttps:\/\/www.bhiva.org\/190403-1<\/a> \u00a0(at 56 mins)<\/p>\n
\n<\/strong>Lion Shahab, University College London
\nhttps:\/\/www.bhiva.org\/190403-4<\/a><\/p>\n
\nSarah Pett, MRC Clinical Trials Unit at UCL
\nhttps:\/\/www.bhiva.org\/190405-3<\/a>\u00a0 (at 13 mins)<\/p>\n
\nCatriona Waitt, University of Liverpool
\nhttps:\/\/www.bhiva.org\/190405<\/a>-3\u00a0(at 42 mins)<\/p>\n